Navigation Links
Surveyed EU5 Rheumatologists Prescribe Biologics to Approximately Half of Their DMARD-Treated Psoriatic Arthritis Patients
Date:11/14/2013

ted by a lack of comparative data which contributed to Simponi's (Merck) ASMR of V (i.e. no added benefit versus marketed comparators) in France, stringent benefit assessments in Germany and the upcoming requirement for a therapeutic positioning report in Spain that will consider clinical benefit and degree of innovation when evaluating emerging drugs. As the cost constrained EU5 markets strive to draw out value for money, increasingly demanding HTA and increasingly complex pricing and reimbursement negotiations are evident in all markets.

The report also finds that the majority of surveyed rheumatologists expect the earliest reimbursed treatment line for Stelara will be as a second- or third-line therapy for conventional DMARD-refractory patients, and surveyed physicians do not foresee apremilast achieving a more favorable reimbursed treatment line, despite the drug's oral delivery and favorable safety profile.

"By the end of 2016, surveyed physicians across the EU5 report they will more likely position emerging therapies Stelara and apremilast in the third- or later-lines than in earlier lines of therapy for their PsA patients," said Decision Resources Analyst Kathryn Beane. "Surveyed physicians cite multiple reasons, including efficacy and a lack of a postmarketing efficacy and safety record (for apremilast) as factors constraining their prescribing."

About Decision Resources
Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources Group company.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, hi
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Surveyed EU5 Oncologists Plan Increased Uptake of Perjeta for HER2-Positive Breast Cancer, But Expect Reimbursement Hurdles for Perjeta Plus Kadcycla
2. Surveyed Physicians Report that Invokana Captures a Small Percentage of Patient Share in the Type 2 Diabetes Drug Market, With Significant Increases Expected Six Months from Now
3. Surveyed U.S. Rheumatologists are Moderately Satisfied with Biologic Agents and Xeljanz to Treat Rheumatoid Arthritis
4. More than a Third of Chronic Kidney Disease-Non-Dialysis Patients are Likely Candidates for FG-4592/ASP1517, According to Surveyed EU5 Nephrologists
5. At One Month Post-Launch, Nearly a Quarter of Surveyed U.S. Oncologists Have Prescribed Tafinlar for Malignant Melanoma, Compared to 15 Percent Who Used Mekinist
6. Should Mircera Reach the U.S. Market, Surveyed Nephrologists State that at Least 40 Percent of CKD-ND and Dialysis Patients are Likely Candidates
7. According to Surveyed U.S. Oncologists, Zytiga is the Patient-Share Leader in First-Line Metastatic Castrate-Resistant Prostate Cancer
8. Surveyed U.S. Neurologists Report Greater Overall Satisfaction with Tecfidera than with Platform Injectables and Other Oral Multiple Sclerosis Therapies
9. At One Month Post-Launch, Nearly One-Quarter of Surveyed U.S. Medical Oncologists Have Prescribed Xofigo to Their Prostate Cancer Patients
10. A Significant Share of Surveyed Treatment-Naive and Prior Failure HCV Patients Plan to Initiate an HCV Treatment Regimen in the Next Year
11. Surveyed U.S. Neurologists Are More Likely Than Payers to Consider Biogen Idecs Tecfidera to be a Breakthrough in the Treatment of Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , August 27, 2015 Itamar ... a private investment in public equity (PIPE) deal, in ... million in Itamar Medical.   Through this ... of Itamar Medical and will work closely with the ... According to the investment agreement, Itamar Medical will ...
(Date:8/27/2015)... Aug. 27, 2015  Zimmer Biomet Holdings, Inc. (NYSE ... announced that it will be participating in the Goldman ... Goldman Sachs offices in London ... Company Founded in 1927 and headquartered in ... leader in musculoskeletal healthcare.  We design, manufacture and market ...
(Date:8/27/2015)... British Columbia and MENLO PARK, ... Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), ... of new cancer therapies, today announced that it will ... ending June 30, 2015 on Friday, September 4, 2015. ... business update conference call and live webcast for investors, ...
Breaking Medicine Technology:Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 2Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 3Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 4Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 5DelMar Pharmaceuticals to Announce Fiscal 2015 Year-End Financial Results on September 4, 2015 2DelMar Pharmaceuticals to Announce Fiscal 2015 Year-End Financial Results on September 4, 2015 3
... Oct. 14 ZyStor Therapeutics, Inc., a biotechnology company ... the treatment of Lysosomal Storage Diseases using the Company,s ... it has received clearance from the U. S. Food ... for its first drug candidate, ZC-701, an enzyme replacement ...
... Company (NYSE: LLY ) today announced the sale ... AG, one of the world,s largest chemical companies. The ... operation with a focus on producing high-quality active pharmaceutical ... In connection with the sale of the site, the ...
Cached Medicine Technology:ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 2ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 3Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 2Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 3Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 4
(Date:8/27/2015)... ... August 27, 2015 , ... In ... legal marijuana industry with the launch of its Doobster platform, a HIPAA-compliant mobile ... order products from their smart phones and tablets. Well, Doobster, “The App ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... scheduled for October 27-29, 2015 in San Jose, CA. The first event ... focus on the void that exists where battery development and energy storage innovation ...
(Date:8/27/2015)... ... August 27, 2015 , ... In addition to its existing Doctor of ... third doctoral program at its main campus in Reading: Doctor of Nursing Practice. , ... to prepare advanced practice nurses for the highest level of clinical nursing practice. ...
(Date:8/27/2015)... ... August 27, 2015 , ... Florida Hospital North Pinellas, located at 1395 South Pinellas Avenue ... of 2016. The new facility will be located at US Highway 19 North and Highlands ... on August 18, and work on the project is slated to begin in September 2015. ...
(Date:8/27/2015)... ... , ... NetDimensions is once again named among TrainingIndustry.com’s annual Top ... only to effectively deliver, curate and administer great programs, but also measure the impact ... six consecutive years, NetDimensions has maintained its position on this Top 20 list. This ...
Breaking Medicine News(10 mins):Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 3Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 4Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 5Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2Health News:Alvernia University Now Offering Three Doctoral Degree Programs 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 3Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 2Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 3
... States added farm-raised fish and shrimp to a growing list ... Thursday. ,The US Food and Drug Administration ... until importers could prove the shipments were free of unsafe ... urged a recall of up to 450,000 Chinese tires because ...
... south Florida has found that Rheumatologists substantially overestimate ... which may lead to inaccurate evaluations ... for lifestyle modifications. ,The rheumatologists consistently ... in performing activities of daily living, such as ...
... labeled as a mentally ill person, which can ... result in a higher rate of unemployment, lower earnings ... Each year, one in four U.S. adults suffers from ... of Mental Health. ,In a recently published ...
... Gehrig's disease mystery, UCLA, Italian chemists may have solved ... key role in a particular form of amyotrophic ... a progressive, fatal neuro-degenerative disorder that strikes without warning. ... and biochemistry, has studied the protein copper-zinc superoxide dismutase ...
... order can rest assured that their male offspring will take after ... to the daughters, especially in the case of red deer. ... that may prove useful for their sons, may not have the ... ,The boffins also state that though this study was carried out ...
... flower essences, is an effective stress reliever which neither ... to any side effects or addiction, says a scientific ... five flower essences-Rock Rose to alleviate terror and panic, ... inattentiveness, Star of Bethlehem to ease shock, and Cherry ...
Cached Medicine News:Health News:US to Detain Seafood Imports from China 2Health News:Rheumatologists Underestimate the Patients Ability to Work 2Health News:Boffins a Step Closer to Solving Puzzle of Lou Gehrig's Disease 2Health News:Boffins a Step Closer to Solving Puzzle of Lou Gehrig's Disease 3Health News:Successful Dads Have Not So Successful Daughters 2
TVL defibrillation leads have a patented coiled-coil design for faster, easier insertion and more precise intracardiac placement. Designed with an integrated bipolar design, the lead enables high-vol...
The Livewire steerable electrophysiology catheter is uniquely designed with an ergonomic handle and patented steering mechanism to provide smooth, precise catheter tip movement, even during lengthy e...
... feature 20 bipolar-spaced electrodes along a ... of mapping resolution in atrial fibrillation ... 20-pole catheter enables more accurate pinpointing ... 10-pole catheter systems. The result: greater ...
Livewire TC steerable ablation catheters are designed for the RF ablation of arrhythmias. They are available in a variety of curves and configurations, including bi-directional catheters for added fl...
Medicine Products: